News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
731,961 Results
Type
Article (41960)
Company Profile (320)
Press Release (689669)
Multimedia
Podcasts (115)
Webinars (20)
Section
Business (207627)
Career Advice (2093)
Deals (36001)
Drug Delivery (117)
Drug Development (82749)
Employer Resources (182)
FDA (16501)
Job Trends (15268)
News (351399)
Policy (33070)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2588)
Accelerated approval (34)
Adcomms (24)
Allergies (143)
Alliances (50378)
ALS (172)
Alzheimer's disease (1699)
Antibody-drug conjugate (ADC) (325)
Approvals (16768)
Artificial intelligence (533)
Autoimmune disease (161)
Automation (42)
Bankruptcy (364)
Best Places to Work (11757)
BIOSECURE Act (22)
Biosimilars (197)
Biotechnology (212)
Bladder cancer (159)
Brain cancer (60)
Breast cancer (645)
Cancer (4876)
Cardiovascular disease (415)
Career advice (1767)
Career pathing (41)
CAR-T (286)
CDC (50)
Celiac Disease (2)
Cell therapy (763)
Cervical cancer (36)
Clinical research (70686)
Collaboration (1753)
Company closure (4)
Compensation (1179)
Complete response letters (60)
COVID-19 (2738)
CRISPR (93)
C-suite (880)
Cystic fibrosis (145)
Data (6302)
Decentralized trials (2)
Denatured (33)
Depression (141)
Diabetes (503)
Diagnostics (6723)
Digital health (49)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (258)
Drug pricing (192)
Drug shortages (28)
Duchenne muscular dystrophy (236)
Earnings (91295)
Editorial (64)
Employer branding (23)
Employer resources (156)
Events (119880)
Executive appointments (1004)
FDA (19657)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1484)
Gene editing (201)
Generative AI (45)
Gene therapy (609)
GLP-1 (999)
Government (4722)
Grass and pollen (7)
Guidances (385)
Healthcare (18966)
HIV (61)
Huntington's disease (45)
IgA nephropathy (83)
Immunology and inflammation (260)
Immuno-oncology (59)
Indications (116)
Infectious disease (3012)
Inflammatory bowel disease (194)
Inflation Reduction Act (15)
Influenza (118)
Intellectual property (256)
Interviews (332)
IPO (16883)
IRA (51)
Job creations (3850)
Job search strategy (1475)
JPM (63)
Kidney cancer (16)
Labor market (91)
Layoffs (567)
Leadership (39)
Legal (8004)
Liver cancer (91)
Longevity (15)
Lung cancer (656)
Lymphoma (381)
Machine learning (42)
Management (59)
Manufacturing (815)
MASH (171)
Medical device (13792)
Medtech (13846)
Mergers & acquisitions (20209)
Metabolic disorders (1297)
Multiple sclerosis (166)
NASH (16)
Neurodegenerative disease (325)
Neuropsychiatric disorders (93)
Neuroscience (2957)
Neurotech (1)
NextGen: Class of 2026 (6580)
Non-profit (4534)
Now hiring (68)
Obesity (613)
Opinion (284)
Ovarian cancer (168)
Pain (201)
Pancreatic cancer (229)
Parkinson's disease (284)
Partnered (33)
Patents (508)
Patient recruitment (502)
Peanut (56)
People (59799)
Pharmaceutical (76)
Pharmacy benefit managers (30)
Phase 1 (22068)
Phase 2 (31166)
Phase 3 (23104)
Pipeline (5424)
Policy (303)
Postmarket research (2574)
Preclinical (9354)
Press Release (64)
Prostate cancer (239)
Psychedelics (50)
Radiopharmaceuticals (293)
Rare diseases (856)
Real estate (6080)
Recruiting (72)
Regulatory (24821)
Reports (57)
Research institute (2413)
Resumes & cover letters (357)
Rett syndrome (27)
RNA editing (16)
RSV (79)
Schizophrenia (150)
Series A (243)
Series B (191)
Service/supplier (11)
Sickle cell disease (97)
Special edition (26)
Spinal muscular atrophy (157)
Sponsored (44)
Startups (3699)
State (2)
Stomach cancer (17)
Supply chain (107)
Tariffs (91)
The Weekly (80)
Vaccines (1036)
Venture capital (94)
Weight loss (393)
Women's health (95)
Worklife (22)
Date
Today (165)
Last 7 days (593)
Last 30 days (2290)
Last 365 days (30324)
2026 (3816)
2025 (30585)
2024 (35726)
2023 (40660)
2022 (51786)
2021 (56339)
2020 (54535)
2019 (46980)
2018 (35385)
2017 (32634)
2016 (32060)
2015 (38110)
2014 (32005)
2013 (26893)
2012 (29013)
2011 (29668)
2010 (27706)
Location
Africa (759)
Alabama (88)
Alaska (7)
Arizona (311)
Arkansas (14)
Asia (40580)
Australia (6554)
California (11413)
Canada (3318)
China (1151)
Colorado (483)
Connecticut (484)
Delaware (341)
Europe (87922)
Florida (1727)
Georgia (358)
Hawaii (3)
Idaho (61)
Illinois (870)
India (67)
Indiana (528)
Iowa (22)
Japan (436)
Kansas (127)
Kentucky (39)
Louisiana (26)
Maine (72)
Maryland (1405)
Massachusetts (8241)
Michigan (327)
Minnesota (634)
Mississippi (5)
Missouri (129)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (78)
New Jersey (3039)
New Mexico (29)
New York (3023)
North Carolina (1529)
North Dakota (8)
Northern California (5573)
Ohio (335)
Oklahoma (21)
Oregon (42)
Pennsylvania (2297)
Puerto Rico (25)
Rhode Island (48)
South America (1133)
South Carolina (66)
South Dakota (1)
Southern California (4446)
Tennessee (176)
Texas (1771)
United States (40653)
Utah (338)
Vermont (1)
Virginia (269)
Washington D.C. (81)
Washington State (943)
West Virginia (4)
Wisconsin (112)
Wyoming (2)
731,961 Results for "immix biopharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immix Biopharma Receives U.S. FDA Breakthrough Therapy Designation for NXC-201
January 29, 2026
·
6 min read
Press Releases
Immix Biopharma Appoints Chief Commercial Officer to Drive NXC-201 Launch
November 13, 2025
·
6 min read
Press Releases
Immix Biopharma Announces Closing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
December 10, 2025
·
2 min read
Press Releases
Immix Biopharma Announces Pricing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
December 8, 2025
·
5 min read
Press Releases
Immix Biopharma’s NXC-201 NEXICART-2 Clinical Trial Results Selected for Oral Presentation at ASH 2025
November 4, 2025
·
5 min read
Press Releases
Immix Biopharma to Present Abstract at the upcoming ASH 2025 Annual Meeting
October 6, 2025
·
3 min read
Press Releases
Immix Biopharma to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
October 15, 2025
·
3 min read
Press Releases
Immix Biopharma to Present at the 37th Annual Piper Sandler Healthcare Conference
October 2, 2025
·
3 min read
Press Releases
Immix Biopharma to Present at the Stifel 2025 Healthcare Conference
August 26, 2025
·
3 min read
Press Releases
Immix Biopharma Announces Other Serious Diseases Strategy
August 7, 2025
·
4 min read
1 of 73,197
Next
